Macroporous open cell polyester amphigel using citric acid and PEO : Solvent absorption, thermal behavior, and slow release of pesticide

Silica modified copper-based alginate/chitosan hybrid hydrogel to control soil fumigant release, reduce emission and enhance bioactivity

Soil fumigant has been extensively used for excellent efficacy on soil-borne diseases. However, rapid emission and insufficient effective duration typically limit its application. In this study, hybrid silica/polysaccharide hydrogel was proposed (SIL/Cu/DMDS) by emulsion-gelation method to encapsulate dimethyl disulfide (DMDS). The orthogonal study was used to optimize the preparation parameters for LC and EE of SIL/Cu/DMDS, which was 10.39 % and 71.05 %, respectively. Compared with silica, the time for 90 % of the total emissions was extended by 4.36 times. The hydrogel possessed a longer persistent duration and the degradation half-life of DMDS was 3.47 times greater than that of silica alone. Moreover, the electrostatic interaction between abundant groups of polysaccharide hydrogel bestowed DMDS with pH-triggered release behavior. Additionally, SIL/Cu/DMDS had excellent water holding and water retention capacity. The bioactivity of the hydrogel was 58.1 % higher than that of DMDS TC due to the strong synergistic effect between DMDS and the carriers (chitosan and Cu²⁺), and showed obvious biosafety to cucumber seeds. This study seeks to provide a potential approach to develop hybrid polysaccharide hydrogel to control soil fumigants release, reduce emission and enhance bioactivity in plant protection.

Folic acid-modified photoluminescent dialdehyde carboxymethyl cellulose crosslinked bionanogels for pH-controlled and tumor-targeted co-drug delivery

This work aimed to fabricate a new photoluminescent bionanogel with both targeted anticancer drug delivery and bioimaging potentials. Briefly, at first photoluminescent carbon dots (CDs) were synthesized from the low-cost and more available black pepper with traditional medicinal properties. The as-synthesized dialdehyde carboxymethyl cellulose (DCMC) was used as a safe crosslinker for gelatin crosslinking in the presence of CDs (CDs/DCMC-Gel). Eventually, the residual amine functional groups of gelatin were used for the conjugation of CDs/DCMC-Gel with folic acid (FA) ((CDs/DCMC-Gel)-FA bionanogels). All employed physicochemical characterization methods approved the (CDs/DCMC-Gel)-FA bionanogels fabrication route. SEM analysis specified the spherical morphology with a diameter of ~70-90 nm for it. Curcumin (CUR) and doxorubicin (DOX) respectively were loaded with drug entrapment efficiency of about 44.0% and 41.4%. The release rate for both drugs in acidic conditions was higher than in physiological conditions. In vitro antitumor experiments; MTT, DAPI staining, cellular uptake, and cell cycle tests showed the superior anticancer effect of the CUR@DOX@(CDs/DCMC-Gel)-FA in comparison with free CUR@DOX. Moreover, the (CDs/DCMC-Gel)-FA acted as a hopeful bio-imaging tool. Taken together, the designed (CDs/DCMC-Gel)-FA could be proposed as a promising nanosystem for efficient chemotherapy.

Controlled release of 5-fluorouracil to melanoma cells using a hydrogel/micelle composites based on deoxycholic acid and carboxymethyl chitosan

5-Fluorouracil (5-FU) is an antimetabolite drug widely used for the treatment of skin cancer. Despite its proven efficacy in treating malignancies, its systemic administration is limited due to severe side effects. To address this issue, topical delivery of 5-FU has been proposed as an alternative approach for the treatment of skin cancer, however, the poor permeability of 5-FU through the skin is still a challenge. Here, we introduced a pH-responsive micellar hydrogel system based on deoxycholic acid micelle (DCA Mic) and carboxymethyl chitosan hydrogel (CMC Hyd) to enhance 5-FU efficacy against skin cancer and reduce its systemic side effects by improving its delivery into the skin. The properties of the Mic/Hyd system were determined by Fourier-transform infrared spectroscopy (FT-IR), dynamic light scattering (DLS), zeta sizer, atomic force microscopy (AFM), scanning electron microscopy (SEM), and transmission electron microscopy (TEM). Drug release studies showed pH-dependent properties of the Hyd. The final formulation was demonstrated to have enhanced anticancer activity than 5-FU against the growth of melanoma cells. The 5-FU@Mic-Hyd could be a promising delivery platform with enhanced efficacy in the management of skin cancer without systemic toxicity.